Intnl. Biotechnology - Holding(s) in Company
RNS Number : 6505NIntl. Biotechnology Trust PLC23 July 2026TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0004559349
Issuer Name
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Border to Coast Pensions Partnership Ltd
City of registered office (if applicable)
Leeds
Country of registered office (if applicable)
UK
4. Details of the shareholder
Name
City of registered office
Country of registered office
Northern Trust Global Services SE
London
UK
5. Date on which the threshold was crossed or reached
22-Jul-2026
6. Date on which Issuer notified
22-Jul-2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
4.930100
0.000000
4.930100
1567913
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB0004559349
1567913
4.930100
Sub Total 8.A
1567913
4.930100%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
11. Additional Information
Teodora Harrop, Head of Compliance and MLRO
0113 487 247512. Date of Completion
23-Jul-2026
13. Place Of Completion
Leeds, United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDHOLUORVRNSUBUAR
Recent news on International Biotechnology Trust
See all newsRCS - Intnl. Biotechnology - Portfolio company Silence acquired by Merck KGaA
RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company
Intnl. Biotechnology - Compliance with Market Abuse Regulation
RCS - Intnl. Biotechnology - QuotedData's In The HotSeat
Intnl. Biotechnology - Director/PDMR Shareholding